Establishing the cost of implementing a performance-based, managed entry agreement for a hypothetical CAR T-cell therapy by Panos Kefalas, Omar Ali, Jesper Jørgensen, Nick Merryfield, Tim Richardson, Adam Meads, Laura Mungapen, Matthew Durdy

Get full text